Andreas Reimann
Impact in
- Biotechnology top 5%
- Transgenic Plants and Applications
- Molecular Biology top 10%
- Renal and related cancers
- CRISPR and Genetic Engineering
- Retinal Development and Disorders
Papers in
-
- Transgenic Plants and Applications 11
- Virology 3
- Co-authors
- Kurt RackéHarald SchwörerH. KilbingerRafael D. FritzOlivier PertzMarco PontoglioKatrin MartinRainer Fischer
- Journals
- Scientific Reports (7 papers)Malaria Journal (5 papers)Endocrinology (3 papers)Journal of Cystic Fibrosis (3 papers)PLoS ONE (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Andreas Reimann
76 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 136
- Biotechnology 185
- Molecular Biology 1.3k
- Gastroenterology 85
- Biophysics 83
- Genetics 362
Countries citing papers authored by Andreas Reimann
This map shows the geographic impact of Andreas Reimann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Reimann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Reimann more than expected).
Fields of papers citing papers by Andreas Reimann
This network shows the impact of papers produced by Andreas Reimann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Reimann. The network helps show where Andreas Reimann may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Reimann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 11 | |
| 5 | 2018 | 17 | |
| 6 | 2017 | 21 | |
| 7 | 2016 | 6 | |
| 8 | 2016 | 19 | |
| 9 | 2016 | 89 | |
| 10 | 2015 | 19 | |
| 11 | 2015 | 43 | |
| 12 | 2014 | 146 | |
| 13 | 2014 | 26 | |
| 14 | 2013 | 32 | |
| 15 | Patientenzentrierte Versorgung bei seltenen Erkrankungen: Perspektive von Patientenorganisationen | 2007 | 3 |
| 16 | 2004 | 85 | |
| 17 | 2004 | 47 | |
| 18 | 2004 | 255 | |
| 19 | Heimkehr des Odysseus | 2000 | 1 |
| 20 | Immunity to cartilage link protein in patients with juvenile rheumatoid arthritis. | 1997 | 13 |
About Andreas Reimann
Andreas Reimann is a scholar working on Biotechnology, Virology, Molecular Biology, Biophysics and Immunology, having authored 79 papers that have together received 2.5k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (11 papers), Transgenic Plants and Applications (11 papers), Malaria Research and Control (8 papers), Cystic Fibrosis Research Advances (6 papers), Mosquito-borne diseases and control (6 papers), Thyroid Disorders and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Plant tissue culture and regeneration (4 papers). The work is most often cited by research in Biotechnology (185 citations), Molecular Biology (1.3k citations), Gastroenterology (85 citations), Biophysics (83 citations) and Genetics (362 citations). Andreas Reimann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Kurt Racké, Harald Schwörer, H. Kilbinger, Rafael D. Fritz, Olivier Pertz, Marco Pontoglio, Katrin Martin, Rainer Fischer, Thomas Hiesberger and Peter Igarashi. Their work appears in journals such as Scientific Reports, Malaria Journal, Endocrinology, Journal of Cystic Fibrosis and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.